Literature DB >> 11942571

P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast.

Joana Paredes1, Fernanda Milanezi, Leda Viegas, Isabel Amendoeira, Fernando Schmitt.   

Abstract

Cadherins are calcium-dependent cell-cell adhesion glycoproteins, separated into several subclasses with distinct adhesive specificities and tissue distribution, which play an important role in many cellular events. We analyse the expression of E-, N- and P-cadherin in a series of ductal carcinoma in situ (DCIS) of the breast, since this disease represents a heterogeneous group, with different risks of progression to invasive breast carcinoma. We also studied the correlation between cadherin expression and DCIS classification systems, namely the Van Nuys and the Holland et al. classification, this latter based on cytonuclear differentiation and cell polarity. Our results showed that, regardless the classification applied, P-cadherin expression is strongly associated with high histological grade of DCIS (P=0.0047) and lack of estrogen receptors (P=0.0008). The use of Holland et al. classification showed a significant correlation between P-cadherin expression and decreased cell polarity (P=0.01). In conclusion, P-cadherin expression seems to be more relevant in DCIS pathogenesis than the altered expression of any other cadherin, including the decrease of E-cadherin expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11942571     DOI: 10.1007/s004280100487

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  16 in total

1.  P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.

Authors:  André Filipe Vieira; Maria Rita Dionísio; Madalena Gomes; Jorge F Cameselle-Teijeiro; Manuela Lacerda; Isabel Amendoeira; Fernando Schmitt; Joana Paredes
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

2.  P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

Authors:  Joana Paredes; Nair Lopes; Fernanda Milanezi; Fernando C Schmitt
Journal:  Virchows Arch       Date:  2006-11-23       Impact factor: 4.064

3.  A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression.

Authors:  Kerri-Ann Norton; Michael Wininger; Gyan Bhanot; Shridar Ganesan; Nicola Barnard; Troy Shinbrot
Journal:  J Theor Biol       Date:  2009-12-16       Impact factor: 2.691

4.  Characterization of PAR1 and FGFR1 expression in invasive breast carcinomas: Prognostic significance.

Authors:  Marta Tiburcio; Sandra M A Costa; Maria DE Fatima Duarte; Fernando C Schmitt; Adhemar Longatto Filho
Journal:  Oncol Lett       Date:  2012-07-17       Impact factor: 2.967

5.  Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas.

Authors:  A Kovács; J Dhillon; R A Walker
Journal:  Mol Pathol       Date:  2003-12

Review 6.  The role and function of cadherins in the mammary gland.

Authors:  Jennifer L Andrews; Alvin C Kim; Julie R Hens
Journal:  Breast Cancer Res       Date:  2012-02-08       Impact factor: 6.466

Review 7.  P-cadherin and the journey to cancer metastasis.

Authors:  André Filipe Vieira; Joana Paredes
Journal:  Mol Cancer       Date:  2015-10-06       Impact factor: 27.401

8.  P-cadherin expression in feline mammary tissues.

Authors:  Ana Catarina Figueira; Ana Sofia Teodósio; Júlio Carvalheira; Manuela Lacerda; Augusto de Matos; Fátima Gärtner
Journal:  Vet Med Int       Date:  2012-10-03

Review 9.  P-cadherin expression in breast cancer: a review.

Authors:  Joana Paredes; Ana Luísa Correia; Ana Sofia Ribeiro; André Albergaria; Fernanda Milanezi; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry.

Authors:  Soheila Korourian; Eric Siegel; Thomas Kieber-Emmons; Behjatolah Monzavi-Karbassi
Journal:  BMC Cancer       Date:  2008-05-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.